Search Results - "Moretz, C"

Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population by Schwab, Phil, Dhamane, Amol D, Hopson, Sari D, Moretz, Chad, Annavarapu, Srinivas, Burslem, Kate, Renda, Andrew, Kaila, Shuchita

“…Patients with chronic obstructive pulmonary disease (COPD) often have multiple underlying comorbidities, which may lead to increased health care resource…”
Get full text

COPD exacerbation frequency and its association with health care resource utilization and costs by Dhamane, Amol D, Moretz, Chad, Zhou, Yunping, Burslem, Kate, Saverno, Kim, Jain, Gagan, Renda, Andrew, Kaila, Shuchita

“…Chronic obstructive pulmonary disease (COPD) exacerbations account for a substantial proportion of COPD-related costs. To describe COPD exacerbation patterns…”
Get full text

Relationship of COPD Exacerbation Severity and Frequency on Risks for Future Events and Economic Burden in the Medicare Fee-For-Service Population by Sethi, Sanjay, Make, Barry J, Robinson, Scott B, Kumar, Shambhavi, Pollack, Michael, Moretz, Chad, Dreyfus, Jill, Xi, Ann, Powell, Dakota, Feigler, Norbert

“…To quantify the effects of moderate and/or severe chronic obstructive pulmonary disease (COPD) exacerbations on future exacerbations and healthcare costs in…”
Get full text

Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities by Kalhan, Ravi, Slade, David, Ray, Riju, Moretz, Chad, Germain, Guillaume, Laliberté, François, Shen, Qin, Duh, Mei Sheng, MacKnight, Sean Dale, Hahn, Beth

“…Comorbidities in patients with chronic obstructive pulmonary disease (COPD) are associated with increased medical costs and risk of exacerbations. This study…”
Get full text

Development and validation of a predictive model to identify patients at risk of severe COPD exacerbations using administrative claims data by Annavarapu, Srinivas, Goldfarb, Seth, Gelb, Melissa, Moretz, Chad, Renda, Andrew, Kaila, Shuchita

“…Patients with COPD often experience severe exacerbations involving hospitalization, which accelerate lung function decline and reduce quality of life. This…”
Get full text

Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study by Moretz, Chad, Sharpsten, Lucie, Bengtson, Lindsay Gs, Koep, Eleena, Le, Lisa, Tong, Junliang, Stanford, Richard H, Hahn, Beth, Ray, Riju

“…Retrospective claims data in patients with chronic obstructive pulmonary disease (COPD) initiating maintenance therapy with inhaled fixed-dose combinations of…”
Get full text

Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol by Moretz, Chad, Bengtson, Lindsay Gs, Sharpsten, Lucie, Koep, Eleena, Le, Lisa, Tong, Junliang, Stanford, Richard H, Hahn, Beth, Ray, Riju

“…This was the first real-world head-to-head study comparing inhaled long-acting muscarinic antagonist/long-acting β -agonist fixed-dose combination treatments…”
Get full text

Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy by Moretz, Chad, Cole, Ashley L, Mu, George, Wu, Benjamin, Guisinger, Amy, Liu, Yunhao, Hahn, Beth, Baylis, Lee

“…Background: Adherence to inhaled maintenance therapy is critical to managing chronic obstructive pulmonary disease (COPD), while increasing rescue medication…”
Get full text

Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients by Dhamane, Amol D, Schwab, Phil, Hopson, Sari, Moretz, Chad, Annavarapu, Srinivas, Burslem, Kate, Renda, Andrew, Kaila, Shuchita

“…Patients with COPD often have multiple comorbidities requiring use of multiple medications, and adherence rates for maintenance COPD (mCOPD) medications are…”
Get full text

Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy by Moretz, Chad, Hahn, Beth, White, John, Goolsby Hunter, Alyssa, Essoi, Breanna, Elliott, Caitlin, Ray, Riju

“…Long-acting muscarinic antagonist/long-acting β -agonist (LAMA/LABA) provide greater improvements in lung function and symptoms than inhaled corticosteroid…”
Get full text

Continuity of Care Assessment Within a Vertically Integrated Care Management Organization Before and After COPD-Related Exacerbations by Fuoco, Morgan Justice, Mularski, Richard A, Wu, Benjamin, Moretz, Chad, McBurnie, Mary Ann, Stanford, Richard H, Crawford, Phillip, Gratie, Daniel, Salas, Bianca

“…There is currently little research describing patient experience and continuity of care immediately prior, during, and following an acute exacerbation of…”
Get full text

Spirometry evaluation to assess performance of a claims-based predictive model identifying patients with undiagnosed COPD by Moretz, Chad, Annavarapu, Srinivas, Luthra, Rakesh, Goldfarb, Seth, Renda, Andrew, Shaikh, Asif, Kaila, Shuchita

“…A claims-based model to predict patients likely to have undiagnosed COPD was developed by Moretz et al in 2015. This study aims to assess the performance of…”
Get full text

Delayed Treatment Modifications For Patients With Type 2 Diabetes Mellitus (T2dm) With Very Poor Glycemic Control by Schwab, P, Saundankar, V, Bouchard, J.R, Moretz, C, Baltz, J

Get full text

Retrospective cohort analysis of the patterns and predictors of metformin treatment change in a medicare advantage patient population from a large national health plan by Hazel-Fernandez, L, Xu, Y, Moretz, C, Meah, Y, Baltz, J, Lian, J, Bouchard, J.R

Get full text

Effect Of Inpatient Admissions On Treatment Regimens In Patients With Type 2 Diabetes by Ellis, J.J, Bouchard, J.R, Saundankar, V, Baltz, J, Meah, Y, Moretz, C

Get full text

Evaluation Of Association Between Diabetes Related Quality Measure Achievement And Diabetes Complications In A Medicare Advantage Population by Ellis, J.J, Bouchard, J.R, Saundankar, V, Moll, K, Baltz, J, Meah, Y, Moretz, C

Get full text

PCV8 Assessment of 30-Day Rehospitalization for Acute Myocardial Infarction in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention: A Comparative Effectiveness Study of Clopidogrel and Prasugrel by Bae, J.P, Faries, D.E, Ernst, F.R, Lipkin, C, Zhao, Z, Moretz, C

Get full text

PCV25 Hospitalization Costs of Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: Comparison Between Clopidogrel and Prasugrel Patients in a United States Hospital Database by Bae, J.P, Ernst, F.R, Lipkin, C, Zhao, Z, Faries, D.E, Moretz, C

Get full text

CO166 Longitudinal Examination of Metastatic Prostate Cancer Utilizing Linked Health Insurance Claims and Germline Genetic Testing Data by Martin, R., Nielsen, S.M., Facio, F.M., Nottke, A.C., Esplin, E.D., Moretz, C., Lacoste, A.M.B.

Get full text

Improving Sexual Function Using a Multidisciplinary Approach for a Breast Cancer Survivor: A Case Report by Moretz, C, Snowden, K

“…Background and Purpose: Breast cancer treatment often results in sexual dysfunction. Treatment affects a woman's body image, relational dynamics, and vaginal…”
Get full text